These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8388193)

  • 21. Kinetics and tolerability of intravitreal pefloxacin in rabbits.
    Cochereau-Massin I; Marrakchi-Benjaafar S; Bauchet J; Vallois JM; Faurisson F; D'Hermies F; Pocidalo JJ
    J Antimicrob Chemother; 1994 Feb; 33(2):231-42. PubMed ID: 8182004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoroquinolones: place in ocular therapy.
    Smith A; Pennefather PM; Kaye SB; Hart CA
    Drugs; 2001; 61(6):747-61. PubMed ID: 11398907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ofloxacin levels after intravitreal injection. Effects of trauma and inflammation.
    Oztürk F; Kortunay S; Kurt E; Ubeyt Inan U; Sami Ilker S; Basci NE; Bozkurt A; Oguz Kayaalp S
    Ophthalmic Res; 1999; 31(6):446-51. PubMed ID: 10474074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences between albino and pigmented rabbit eyes in the intraocular pharmacokinetics of sparfloxacin.
    Fukuda M; Sasaki K
    Drugs; 1995; 49 Suppl 2():314-6. PubMed ID: 8549346
    [No Abstract]   [Full Text] [Related]  

  • 25. Intravitreal taurolidine against experimental Staphylococcus epidermidis endophthalmitis in rabbits.
    Oguz H; Zeyrek FY; Ozardali I; Oguz E; Gurkan T
    Curr Eye Res; 2004 Apr; 28(4):225-32. PubMed ID: 15259291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular kinetics of pefloxacin after intramuscular administration in albino and pigmented rabbits.
    Cochereau-Massin I; Bauchet J; Faurisson F; Vallois JM; Lacombe P; Pocidalo JJ
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1112-5. PubMed ID: 1929251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moxalactam (Moxam) in the treatment of experimental staphylococcal endophthalmitis.
    Leeds NH; Peyman GA; House B
    Ophthalmic Surg; 1982 Aug; 13(8):653-6. PubMed ID: 6215601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis.
    Ermis SS; Cetinkaya Z; Kiyici H; Inan UU; Ozturk F
    Curr Eye Res; 2007 Apr; 32(4):337-44. PubMed ID: 17453955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraocular Pharmacokinetics of Povidone-Iodine and Its Effects on Experimental Staphylococcus epidermidis Endophthalmitis.
    Kim KH; Cao J; Yoo JW; Yoon IS; Jung JW; Lee JE; Byon IS
    Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6694-700. PubMed ID: 26469754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibacterial activity of sparfloxacin against experimental renal infections in mice.
    Georgopoulos A; Feistauer SM; Graninger W; Pfleger S; Georgopoulos M
    Antimicrob Agents Chemother; 1992 Feb; 36(2):505-7. PubMed ID: 1318685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of aztreonam in rabbit eyes.
    Barza M; McCue M
    Antimicrob Agents Chemother; 1983 Oct; 24(4):468-73. PubMed ID: 6685992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of newer cephalosporins after subconjunctival and intravitreal injection in rabbits.
    Barza M; Lynch E; Baum JL
    Arch Ophthalmol; 1993 Jan; 111(1):121-5. PubMed ID: 8424709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis.
    Ferrer C; Rodríguez A; Abad JL; Fernandez J; Alió JL
    Br J Ophthalmol; 2008 May; 92(5):678-82. PubMed ID: 18211926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ocular penetration of oral sparfloxacin in humans.
    Bron AM; Pechinot AP; Garcher CP; Guyonnet GA; Kazmierczak AM; Schott DA; Lecoeur H
    Am J Ophthalmol; 1994 Mar; 117(3):322-7. PubMed ID: 8129004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci.
    Entenza JM; Blatter M; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2683-8. PubMed ID: 7695248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit.
    Dajcs JJ; Thibodeaux BA; Hume EB; Zheng X; Sloop GD; O'Callaghan RJ
    Curr Eye Res; 2001 Jun; 22(6):451-7. PubMed ID: 11584345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intravitreal triamcinolone acetonide in the treatment of experimental Staphylococcus epidermidis endophthalmitis.
    Hosseini H; Mehryar M; Eghtedari M; Ahmadi F; Nowroozizadeh S
    Curr Eye Res; 2009 Feb; 34(2):145-51. PubMed ID: 19219686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal pharmacokinetics of liposome-encapsulated amikacin in a rabbit model.
    Zeng S; Hu C; Wei H; Lu Y; Zhang Y; Yang J; Yun G; Zou W; Song B
    Ophthalmology; 1993 Nov; 100(11):1640-4. PubMed ID: 8233389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus-induced experimental endophthalmitis.
    De Kaspar HM; Ta CN; Engelbert M; Mette M; Thiel M; Kampik A
    Retina; 2008 Feb; 28(2):326-32. PubMed ID: 18301039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis.
    Kim JY; Kim SY
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1742-7. PubMed ID: 21169530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.